id	submitter_id	entity_type	entity_id	category	classification	created_datetime	status	notes
410fb727-fc1a-54a9-963c-51c0560659a2	28339	case	a48996be-7dae-451a-8129-9de8dfe7221a	Neoadjuvant therapy	Notification	2015-05-01T00:00:00	Approved	After adding pharmaceutical forms it was discovered that this patient received Cisplatin and Pemetrexed 2 months prior to the TCGA cancer procurement.
65f590fe-dda1-52af-bf6a-20bef595806e	23098	case	a20fb646-2a9e-42ac-a2cc-ff3d6a0625fa	Item may not meet study protocol	Observation	2014-10-03T00:00:00	Approved	Patient was diagnosed 2 years prior to cancer procurement with no surgery until TCGA tumor was resected, therefore this may be considered a progression.  Patient was treated with pleurodesis more than 90 days prior to cancer procurement which is acceptable.
75dd1d21-b1eb-55de-b078-4f2a7c2caf77	23097	case	cb245767-f9d2-4cca-95f0-f3d247c05f01	Neoadjuvant therapy	Notification	2014-10-03T00:00:00	Approved	During Enrollment it was found that the patient received raditiaion treatment 2 months prior to TCGA tumor procurement.
f079bf5a-00e9-5b63-8ccb-4506f7f4cc74	20692	case	aaace369-0a47-4176-811b-61cd42bf647f	Neoadjuvant therapy	Notification	2014-06-12T00:00:00	Approved	Pleurodesis < 90 days from sample procurement
32899629-7b35-5c77-b4e3-8d6aad3928e2	20693	case	e90bfe17-2e5b-47ed-b986-b3d4181f2bf6	Neoadjuvant therapy	Notification	2014-06-12T00:00:00	Approved	Pleurodesis < 90 days from sample procurement